We are thrilled that Sienza Energy is the latest company to join the Kairos portfolio. Sienza Energy is a...

Read more

We are pleased to announce that our portfolio company Symbiotix has entered into a process development and manufacturing agreement...

Read more

Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...

Read more

We are pleased to announce that our portfolio company Provivi, Inc. closed on the first $21 million of a...

Read more

We are pleased to announce that Symbiotix Biotherapies, Inc. is the latest company to join the Kairos portfolio. Founded in...

Read more

We are delighted to announce that MixComm Inc. is the latest company to join the Kairos portfolio. MixComm Inc....

Read more

We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...

Read more

We are delighted to announce that Chimera Bioengineering is the latest company to join the Kairos portfolio. Founded in...

Read more

We are pleased to announce that Transient Plasma Systems (TPS) is the latest company to join the Kairos portfolio....

Read more

Healthline recently published an article on the importance of implantable drugs, including Delpor’s implant devices. The first half of...

Read more